Trial Details

Not Recruiting
Basic Information
Clinical ID c2807
Identifier JPRN-UMIN000029828
Trial Title Multicenter prospective intervention study to evaluate the efficacy of prophylaxis for venous thromboembolism with antithrombotic drugs in Japanese inflammatory bowel disease inpatients. - Efficacy of prophylaxis for venous thromboembolism with antithrombotic drugs in Japanese IBD inpatients.
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Inflammatory bowel disease
Interventions UFH is administrated with a subcutaneous injection of 5000 units every 12 hours or intravenous drip infusion of 10000 units for 24 hours. UFH is administered for at least 3 days, and a continuation or completion of administration of UFH since fourth days is judged by doctor in charge, consdering disease activity, reduction of other risks against VTE and so on.
Participant Information
Sponsor Asahikawa Medical Universtity
City -
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2020-12-31